Liposarcoma laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The definitive diagnosis of liposarcoma is made by biopsy, which also provides histopathological classification of the liposarcoma's subtype. Other pertinent laboratory findings include anemia and elevated BUN due to GI bleeding and elevated creatinine among patients with obstructive nephropathy.
The pertinent laboratory findings of liposarcoma include [[anemia]] and [[BUN|elevated BUN]] due to GI bleeding and elevated [[creatinine]] among patients with [[obstructive nephropathy]].


==Laboratory findings==
==Laboratory findings==
Line 21: Line 21:
  | pmid = 25202112
  | pmid = 25202112
}}</ref>
}}</ref>
===Biopsy===
Although imaging may be helpful in the diagnosis of liposarcoma, the optimal method for diagnosis of liposarcoma is by biopsy. A biopsy also provides important histopathological information requires to identify the subtype of the liposarcoma.
{| style="border: 0px; font-size: 90%; margin: 3px; width: 700px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Subtype}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Findings}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Atypical Lipomatous Neoplasm (ALN)/Well-Differentiated Liposarcoma (WDL)
| style="padding: 5px 5px; background: #F5F5F5;" | 4 subtypes:<br>
*Lipoma-like<br>
*Sclerosing<br>
*Spindle cell<br>
*Inflammatory<br>
Multivacuolated lipoblasts and spindle cells with hyperchromatic nuclei are often observed.<br>Other findings include fibrotic areas and atypical stroma cells.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | De-differentiated Liposarcoma
| style="padding: 5px 5px; background: #F5F5F5;" | Abrupt transition from a low-grade to a high-grade differentiation within the same mass of a well-differentiated liposarcoma.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Myxoid liposarcoma
| style="padding: 5px 5px; background: #F5F5F5;" |Multinodular mass with round cells and hyaluronic acid matrix.<br>High cellularity at the periphery and low cellularity at the center of the mass. Mitotic activity is normal and the nuclei are normochromatic.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Pleomorphic liposarcoma
| style="padding: 5px 5px; background: #F5F5F5;" | Pleomorphic lipoblasts with hyperchromatic nuclei, acidophilic cytoplasm, and eosinophilic hyaline globules.<br>Spindle cells and multinucleated giant cells may be observed.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Mixed-type Liposarcoma
| style="padding: 5px 5px; background: #F5F5F5;" | Mixed features of myxoid, pleomorphic, and well-differentiated liposarcoma.
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2| <small>Table adapted from Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Geneva:IARC Press; 2002<ref>{{cite book | last = Fletcher | first = Christopher | title = Pathology and genetics of tumours of soft tissue and bone | publisher = IARC Press | location = Lyon | year = 2002 | isbn = 9283224132 }}</ref> and Enzinger and Weiss's Soft Tissue Tumors , 6th Edition <ref>{{cite book | last = Goldblum | first = John | title = Enzinger and Weiss's soft tissue tumors | publisher = Saunders/Elsevier | location = Philadelphia, PA | year = 2014 | isbn = 978-0-323-08834-3 }}</ref> </small>
|-
|}
{|
|[[File:Well Differentiated Liposarcoma.jpg|thumb|250px|Well-differentiated liposarcoma.<br>Retrieved from Wikimedia Commons. Original image courtesy of Panoraia Paraskeva, Paraskevas Katsaronis, Eleftherios D Spartalis, et al. Giant liposarcoma of the back with 4 types of histopathology: a case report. Cases Journal. 2009; 2:9339(Open Access)]]
|[[File:Dedifferentiated Liposarcoma.jpg|thumb|250px|De-differentiated liposarcoma.<br>Retrieved from Wikimedia Commons. Image by user: Nephron, licensed under GNU Free Documentation License]]
|[[File:Dedifferentiated Liposarcoma 2.jpg|thumb|250px|De-differentiated liposarcoma.<br>Retrieved from Wikimedia Commons. Image by user: Nephron, licensed under GNU Free Documentation License]]
|-
|[[File:Dedifferentiated Liposarcoma 3.jpg|thumb|250px|De-differentiated liposarcoma.<br>Retrieved from Wikimedia Commons. Image by user: Nephron, licensed under GNU Free Documentation License]]
|[[File:Dedifferentiated Liposarcoma 4.jpg|thumb|250px|De-differentiated liposarcoma.<br>Retrieved from Wikimedia Commons. Image by user: Nephron, licensed under GNU Free Documentation License]]
|}


==References==
==References==

Revision as of 21:01, 25 August 2015

Liposarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Liposarcoma laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liposarcoma laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liposarcoma laboratory findings

CDC on Liposarcoma laboratory findings

Liposarcoma laboratory findings in the news

Blogs on Liposarcoma laboratory findings

Directions to Hospitals Treating Liposarcoma

Risk calculators and risk factors for Liposarcoma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

The pertinent laboratory findings of liposarcoma include anemia and elevated BUN due to GI bleeding and elevated creatinine among patients with obstructive nephropathy.

Laboratory findings

  • There are no specific laboratory tests for the diagnosis of liposarcoma.
  • Patients with ureteral or renal involvement, an elevated creatinine may be observed.
  • Anemia and elevated BUN may be present among patients with liposarcoma assoicated with GI bleeding.[1]
  • The level of D-dimer has been studied as a marker for the differential diagnosis of lipoma and well-differentiated liposarcoma. Results have demonstrated that liposarcoma may have increased levels of D-dimer compared to lipoma.[2]

References

  1. Nennstiel, Simon; Mollenhauer, Martin; Schlag, Christoph; Becker, Valentin; Neu, Bruno; Hüser, Norbert; Gertler, Ralf; Schmid, Roland M.; von Delius, Stefan (2014). "Small Bowel Pleomorphic Liposarcoma: A Rare Cause of Gastrointestinal Bleeding". Case Reports in Gastrointestinal Medicine. 2014: 1–4. doi:10.1155/2014/391871. ISSN 2090-6528.
  2. Akira Yoshiyama, Takeshi Morii, Takashi Tajima, Takayuki Aoyagi, Keita Honya, Kazuo Mochizuki, Kazuhiko Satomi & Shoichi Ichimura (2014). "D-dimer Levels in the Differential Diagnosis Between Lipoma and Well-differentiated Liposarcoma". Anticancer research. 34 (9): 5181–5185. PMID 25202112. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources